How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Cytation 9 cell imaging multimode reader that combines high-content imaging with multimode microplate reading in a single platform. These developments together reshape Agilent's position in genomics and lab automation, potentially broadening its scientific relevance while sharpening its competitive product offering. We'll now examine how the CRISPR patent resolution reshapes Agilent's investment narrative, including its role in enabling broader genomic research. Find 62 companies with promising cash flow potential yet trading below their fair value Agilent Technologies Investment Narrative Recap To own Agilent, you need to believe in steadily rising demand for lab tools and diagnostics across pharma, biotech, and regulated testing, supported by recurring revenue and ongoing product refreshes. The CRISPR patent loss looks more reputational than financial at this stage, while the key near term catalyst remains execution in pharma and biopharma instruments, with the biggest cur
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents [Yahoo! Finance]Yahoo! Finance
- Infection Control Market Size Outlook 2026-2031: In-House Programs Dominate Service Delivery Mode with 53.40% Share, Reports Mordor Intelligence [TheStreet.com]TheStreet.com
- Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode ReaderBusiness Wire
- Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)? [Yahoo! Finance]Yahoo! Finance
- Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) CarcinomaBusiness Wire
A
Earnings
- 2/25/26 - Miss
A
Sec Filings
- 4/6/26 - Form 8-K/A
- 4/3/26 - Form 8-K
- 4/2/26 - Form 4
- A's page on the SEC website